K D L Pharma Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 9.90 Cr
- Company Age 35 Year, 6 Months
- Last Filing with ROC 31 Mar 2014
- Open Charges ₹ 27.69 Cr
About K D L Pharma
Company Details
-
Location
Kolkata, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231WB1989PLC047198
-
Company No.
047198
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
07 Jul 1989
-
Date of AGM
30 Sep 2014
-
Date of Balance Sheet
31 Mar 2014
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at K D L Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nurani Ramanathan
|
Manager | 22-Apr-2006 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Shyam Rathi
|
Director | 01-Jun-2007 | Current |
|
Deepak Kaushik
|
Director | 20-Aug-2003 | Current |
|
Kamal Sharma
|
Director | 23-Aug-2011 | Current |
Financial Performance of K D L Pharma.
Enhance accessibility to K D L Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of K D L Pharma?
Unlock access to K D L Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Uniworth Biotech LimitedShyam Rathi is a mutual person
-
Comfort (India) Limited
Shyam Rathi is a mutual person
-
Madgul Estates Pvt Ltd
Shyam Rathi is a mutual person
-
Fibres & Fabrics Pvt Ltd
Shyam Rathi is a mutual person
-
Texworth Credit & Commercial Pvt Ltd
Shyam Rathi is a mutual person
-
Rachit Textrade Pvt Ltd
Shyam Rathi is a mutual person
Charges (Loans)
₹27.69 Cr
₹0
Charges Breakdown by Lending Institutions
- The Hongkong Corporation Ltd. : 10.00 Cr
- State Bank Of India : 7.64 Cr
- Allahabad Bank : 4.84 Cr
- I.D.B.Of India : 2.52 Cr
- I F.C.Of India : 1.69 Cr
- Others : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Jun 1997 | State Bank Of India | ₹4.10 Cr | Open |
| 04 Jul 1994 | The Hongkong Corporation Ltd. | ₹5.00 Cr | Open |
| 04 Jan 1994 | The Hongkong Corporation Ltd. | ₹5.00 Cr | Open |
| 24 Jun 1992 | Allahabad Bank | ₹4.84 Cr | Open |
| 09 Apr 1992 | State Bank Of India | ₹3.54 Cr | Open |
How Many Employees Work at K D L Pharma?
Unlock and access historical data on people associated with K D L Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of K D L Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped K D L Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
